Edgewise Therapeutics Statistics Share Statistics Edgewise Therapeutics has 105.2M
shares outstanding. The number of shares has increased by 12.19%
in one year.
Shares Outstanding 105.2M Shares Change (YoY) 12.19% Shares Change (QoQ) 10.5% Owned by Institutions (%) 99.99% Shares Floating 77.2M Failed to Deliver (FTD) Shares 7 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 11.07M, so 10.53% of the outstanding
shares have been sold short.
Short Interest 11.07M Short % of Shares Out 10.53% Short % of Float 12.36% Short Ratio (days to cover) 18.86
Valuation Ratios The PE ratio is -18.44 and the forward
PE ratio is -6.25.
Edgewise Therapeutics's PEG ratio is
2.41.
PE Ratio -18.44 Forward PE -6.25 PS Ratio 0 Forward PS 656.9 PB Ratio 5.37 P/FCF Ratio -22.36 PEG Ratio 2.41
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Edgewise Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 19.93,
with a Debt / Equity ratio of 0.01.
Current Ratio 19.93 Quick Ratio 19.93 Debt / Equity 0.01 Debt / EBITDA -0.04 Debt / FCF -0.04 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.14M Employee Count 117 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -23.81% in the
last 52 weeks. The beta is 0.27, so Edgewise Therapeutics's
price volatility has been higher than the market average.
Beta 0.27 52-Week Price Change -23.81% 50-Day Moving Average 14.05 200-Day Moving Average 22.3 Relative Strength Index (RSI) 36.2 Average Volume (20 Days) 830,159
Income Statement
Revenue n/a Gross Profit n/a Operating Income -158.83M Net Income -133.81M EBITDA -131.52M EBIT -133.81M Earnings Per Share (EPS) -1.45
Full Income Statement Balance Sheet The company has 41.67M in cash and 4.74M in
debt, giving a net cash position of 36.93M.
Cash & Cash Equivalents 41.67M Total Debt 4.74M Net Cash 36.93M Retained Earnings -378.58M Total Assets 454.39M Working Capital 422.06M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -109.03M
and capital expenditures -1.31M, giving a free cash flow of -110.34M.
Operating Cash Flow -109.03M Capital Expenditures -1.31M Free Cash Flow -110.34M FCF Per Share -1.19
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
